X4 Pharmaceuticals Inc (XFOR)

X4 Pharmaceuticals (XFOR) Stock Price & Analysis


XFOR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.65 - $2.41
Previous Close$1.93
Average Volume (3M)3.05M
Market Cap
Enterprise Value$145.63M
Total Cash (Recent Filing)$93.41M
Total Debt (Recent Filing)$5.11M
Price to Earnings (P/E)-1.5
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.31
Shares Outstanding122,207,488
10 Day Avg. Volume7,061,886
30 Day Avg. Volume3,050,632
Standard Deviation0.35
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)4813.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio40.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue990.68
Enterprise Value/Gross Profit743.01
Enterprise Value/Ebitda-2.12
Price Target Upside86.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was X4 Pharmaceuticals Inc’s price range in the past 12 months?
X4 Pharmaceuticals Inc lowest stock price was $0.65 and its highest was $2.41 in the past 12 months.
    What is X4 Pharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is X4 Pharmaceuticals Inc’s upcoming earnings report date?
    X4 Pharmaceuticals Inc’s upcoming earnings report date is Aug 03, 2023 which is in 63 days.
      How were X4 Pharmaceuticals Inc’s earnings last quarter?
      X4 Pharmaceuticals Inc released its earnings results on May 04, 2023. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.212 by $0.052.
        Is X4 Pharmaceuticals Inc overvalued?
        According to Wall Street analysts X4 Pharmaceuticals Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does X4 Pharmaceuticals Inc pay dividends?
          X4 Pharmaceuticals Inc does not currently pay dividends.
          What is X4 Pharmaceuticals Inc’s EPS estimate?
          X4 Pharmaceuticals Inc’s EPS estimate is -$0.16.
            How many shares outstanding does X4 Pharmaceuticals Inc have?
            X4 Pharmaceuticals Inc has 121,207,490 shares outstanding.
              What happened to X4 Pharmaceuticals Inc’s price movement after its last earnings report?
              X4 Pharmaceuticals Inc reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.212. Following the earnings report the stock price went up 4.054%.
                Which hedge fund is a major shareholder of X4 Pharmaceuticals Inc?
                Among the largest hedge funds holding X4 Pharmaceuticals Inc’s share is Perceptive Advisors LLC. It holds X4 Pharmaceuticals Inc’s shares valued at 4M.


                  X4 Pharmaceuticals Stock Smart Score

                  The X4 Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  X4 Pharmaceuticals Inc

                  X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.


                  Top 5 ETFs holding XFOR

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold XFOR. The ETFs are listed according to market value of XFOR within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Corvus Pharmaceuticals
                  Voyager Therapeutics
                  Kala Pharmaceuticals
                  Adverum Biotechnologies

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis